Sector dividends Monte Rosa Therapeutics, Inc.
Stocks
GLUE
US61225M1027
Biotechnology & Medical Research
|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 18.67 USD | +1.97% |
|
+3.04% | +19.07% |
Main competitors
| Dividend Yield (N) | Dividend Yield (N+1) | P/E (N) | Price to Book (N) | EV / Sales (N) | EV / EBITDA (N) | EV / EBIT (N) | Capi.($) | ||
|---|---|---|---|---|---|---|---|---|---|
| - | - | -11.28x | - | - | - | - | 1.58B | ||
| 1.09% | 1.24% | 30.2x | 3.87x | 5.35x | 16.57x | 23.25x | 43.24B | ||
| -.--% | -.--% | -20.85x | 15.22x | 310.12x | -19.1x | -18.78x | 35.25B | ||
| -.--% | -.--% | 40.55x | 6.05x | 4.04x | 25.86x | 30.6x | 30.22B | ||
| -.--% | -.--% | 20.42x | 3.87x | 2.41x | 10.42x | 15.88x | 28.01B | ||
| 0.44% | 0.47% | 28.37x | 2.09x | 7.35x | 18.9x | 22.56x | 24.08B | ||
| -.--% | -.--% | 26.74x | 13.39x | 4.27x | 19.45x | 20.4x | 13.01B | ||
| 1.21% | 1.42% | 22.04x | 2.31x | 1.91x | 8.4x | 13.3x | 12.7B | ||
| -.--% | -.--% | -21.01x | 313.43x | 13.85x | -20.61x | -20.03x | 12.54B | ||
| -.--% | -.--% | 22.13x | 1.1x | 1.64x | 9.93x | 11.37x | 10.78B | ||
| -.--% | -.--% | -23.77x | 21.2x | 5.8x | 142.18x | -447.42x | 8.59B | ||
| 0.58% | 0.58% | 47.69x | 4.04x | 7.14x | 20.26x | 22.2x | 8.71B | ||
| -.--% | -.--% | 29.6x | 2.65x | 2.74x | 10.68x | 12.97x | 8.75B | ||
| -.--% | -.--% | -20x | 7.55x | 1748.03x | -16.76x | -15.95x | 8.46B | ||
| -.--% | -.--% | -22.85x | 38.77x | 1666.23x | -23.8x | -24.65x | 7.83B | ||
| -.--% | 0.52% | 17.3x | 1.97x | 3.72x | 9.92x | 12.71x | 7.5B | ||
| -.--% | -.--% | -115.73x | 4.16x | 4.77x | 25.28x | 151.86x | 7.67B | ||
| -.--% | -.--% | -28.23x | 7.27x | 80.98x | -18.17x | -17.53x | 8.18B | ||
| -.--% | -.--% | 29.5x | - | 13.4x | 23.88x | 25.96x | 7.4B | ||
| Average | 0.18% | 0.23% | 2.67x | 26.41x | 215.76x | 13.52x | -10.07x | 14.97B | |
| Weighted average by Cap. | 0.28% | 0.33% | 10.50x | 21.44x | 143.47x | 11.45x | 0.02x |
- Stock Market
- Stocks
- GLUE Stock
- Sector Monte Rosa Therapeutics, Inc.
- Sector dividends
Select your edition
All financial news and data tailored to specific country editions
















